iSpecimen Inc. Interview to Air on the RedChip Money Report® on Bloomberg TV
08/12/2021 - 09:00 AM
LEXINGTON, Mass. , Aug. 12, 2021 /PRNewswire/ -- iSpecimen Inc. (Nasdaq: ISPC) , an online marketplace for human biospecimens ("iSpecimen" or the "Company") , today announced that an interview with its CEO and President, Dr. Christopher Ianelli , will air on The RedChip Money Report® on Bloomberg TV, at 7 p.m. Eastern Time (ET) on August 14, 2021 . Bloomberg TV is available in an estimated 73 million homes across the United States .
The RedChip Money Report® is produced by RedChip Companies Inc., an international investor relations and media firm with 30 years' experience focused on Discovering Tomorrow's Blue Chips Today ™. The RedChip Money Report® delivers insightful commentary on small-cap investing, interviews with Wall Street analysts, financial book reviews, as well as featured interviews with executives of public companies.
You can also watch the interview online at https://www.youtube.com/watch?v=ETILpteYxhg .
About iSpecimen
iSpecimen offers an online marketplace for human biospecimens, connecting life scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. For more information about iSpecimen, please visit www.ispecimen.com .
Forward Looking Statements
This press release may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements are characterized by future or conditional verbs such as "may," "will," "expect," "intend," "anticipate," believe," "estimate" and "continue" or similar words. You should read statements that contain these words carefully because they discuss future expectations and plans, which contain projections of future results of operations or financial condition or state other forward-looking information.
Forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Many factors could cause actual future events to differ materially from the forward-looking statements in this press release, including but not limited to the risks factors contained in the Company's filings with the Securities and Exchange Commission, which are available for review at www.sec.gov . Forward-looking statements speak only as of the date they are made. New risks and uncertainties arise over time, and it is not possible for the Company to predict those events or how they may affect the Company. If a change to the events and circumstances reflected in the Company's forward-looking statements occurs, the Company's business, financial condition and operating results may vary materially from those expressed in the Company's forward-looking statements.
Readers are cautioned not to put undue reliance on forward-looking statements, and the Company assumes no obligation and do not intend to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.
For further information, please contact:
Investor Relations Contact:
Dave Gentry Dave@redchip.com
Media Contact:
Kaitlynn Cooney kcooney@brodeur.com
https://www.prnewswire.com/news-releases/ispecimen-inc-interview-to-air-on-the-redchip-money-report-on-bloomberg-tv-301354292.html
SOURCE iSpecimen Inc.
ISPC Rankings
N/A Ranked by Stock Gains
ISPC Stock Data
Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
Sector
Professional, Scientific, and Technical Services
About ISPC
headquartered in lexington, ma, ispecimen is the marketplace for human biospecimens, providing researchers with the specimens they need from the patients they want. the privately held company has developed the ispecimen marketplace, an online platform connecting healthcare organizations that have access to patients and specimens with the scientists who need them. proprietary, cloud-based technology enables researchers to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers, and other healthcare organizations. researchers easily and compliantly gain access to specimens to drive scientific discovery. partner sites gain an opportunity to contribute to biomedical discovery as well as their bottom line. and ultimately, healthcare advances for all.
